Grant: Engage Plus Grants Program
University of Alberta
$12,500.00
Development of a customized diagnostic test for lung cancer
FY 2016-17
Summary
The polyamine pathway has been demonstrated to be significantly up-regulated in cancer cells. Preliminary studies by our industry collaborator, BioMark Diagnostics Inc, have indicated that metabolites of the polyamine pathway may serve as robust diagnostic biomarkers for lung cancer. In our previously funded NSERC Engage project, we measured polyamine metabolites in lung cancer by liquid chromatography-mass spectrometry (LC-MS) analysis. A number of other metabolites were also measured, including lipids, biogenic amines, and amino acids. Bioinformatics and statistical analysis revealed that the inclusion of 4 of these additional metabolites increased the sensitivity and specificity for diagnosing lung cancer compared to the sensitivity and specificity provided by the polyamine metabolites alone. Based on this work and consultation with BioMark, we have identified 13 metabolite biomarkers that were able to distinguish between control (healthy) and lung cancer samples.We are proposing to build from our NSERC Engage project by validating this extended comprehensive set of 13 metabolite biomarkers in a larger lung cancer cohort. The goals of this project are to incorporate the 4 additional non-polyamine biomarkers into a customized LC-MS test in order measure the concentrations of all 13 markers in lung cancer patients to revalidate our earlier discoveries. Our overall objective is to determine the feasibility of these metabolites as a diagnostic biomarker panel for lung cancer. If we are able to confirm that these metabolites indeed serve as a robust biomarker panel we will convert the LC-MS assay into a customized kit, complete with protocols, reagents and software required.
Program
Engage Plus Grants Program
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
492629-2016
Name nom
Wishart, David
Department département
Computing Science
Organization id
9
Institution établissement
University of Alberta
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2016
Competition year année de concours
2016
Award amount
12500
Program id
EGP2
Program name en
Engage Plus Grants Program
Program name fr
Programme de subvention d'engagement partenarial Plus
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1555
Committee name en
Prairie Internal Decision Committee
Committee name fr
Comité de décision interne pour les Prairies
Area of application code
702
Area of application group en
Transportation systems and services
Area of application group fr
Services et systèmes de transport
Area of application en
Water
Area of application fr
Maritime
Research subject code
1501
Research subject group en
Environmental engineering
Research subject group fr
Génie de l'environnement
Research subject en
Water quality, pollution
Research subject fr
Qualité de l'eau, pollution
Partie
1
Nb partie
1
Application title
Development of a customized diagnostic test for lung cancer
Keyword
NSERC
Application summary
The polyamine pathway has been demonstrated to be significantly up-regulated in cancer cells. Preliminary studies by our industry collaborator, BioMark Diagnostics Inc, have indicated that metabolites of the polyamine pathway may serve as robust diagnostic biomarkers for lung cancer. In our previously funded NSERC Engage project, we measured polyamine metabolites in lung cancer by liquid chromatography-mass spectrometry (LC-MS) analysis. A number of other metabolites were also measured, including lipids, biogenic amines, and amino acids. Bioinformatics and statistical analysis revealed that the inclusion of 4 of these additional metabolites increased the sensitivity and specificity for diagnosing lung cancer compared to the sensitivity and specificity provided by the polyamine metabolites alone. Based on this work and consultation with BioMark, we have identified 13 metabolite biomarkers that were able to distinguish between control (healthy) and lung cancer samples.We are proposing to build from our NSERC Engage project by validating this extended comprehensive set of 13 metabolite biomarkers in a larger lung cancer cohort. The goals of this project are to incorporate the 4 additional non-polyamine biomarkers into a customized LC-MS test in order measure the concentrations of all 13 markers in lung cancer patients to revalidate our earlier discoveries. Our overall objective is to determine the feasibility of these metabolites as a diagnostic biomarker panel for lung cancer. If we are able to confirm that these metabolites indeed serve as a robust biomarker panel we will convert the LC-MS assay into a customized kit, complete with protocols, reagents and software required.